Skippet, a pioneer in AI and Natural Language Processing (NLP), is changing the way people interact with computers.
“Solving a problem or implementing a solution should be as easy as describing it.” – Jacob, Co-Founder & CEO at Skippet
This week Skippet announced the closing of its $2.2m seed round led by VC fund Neo with participation from Wedbush Ventures, Studio Management, Gaingels, Assure, and prominent US and European angel investors.
Skippet empowers everyone to create custom digital solutions to solve problems without needing to code. Write out your problem in plain English, and Skippet uses its knowledge of your existing systems and integrations, along with state-of-the-art language models to create or modify an application or workflow. This is made possible by Skippet’s proprietary architecture which translates natural language into fit-for-purpose solutions.
More from News
- The EU AI Act Is Finally Here: What Changes In 2026 And What Can Wait Until 2027?
- Google Stock Slides As Demis Hassabis Steps Back From DeepMind – What Happens Next?
- Inside The Leaked File Exposing TikTok’s Deliberate Safety Exclusions
- The UK Government Wants Your Encrypted Data And Apple Is Fighting Back
- Seriös Group Launches New Research Exposing ‘Chief Information Overload’ Facing UK Data Leaders
- From Driverless Cars To Parentless Parenting: Is Sam Altman Running Out Of Things To Outsource?
- How Does Google Intend On Producing 15 Million AI Chips Over The Next Two Years?
- TikTok Parent ByteDance Has Officially Passed The $4 Billion Mark In AI Revenue
Skippet’s founders believe that, from individuals to large organisations, people should be able to seamlessly customise software in a world where business needs are always changing. Skippet aims to make inflexible and expensive software redundant.
The team was inspired to build Skippet by their experience in helping over 200 organisations (schools & businesses) through the COVID-19 pandemic. The company developed MyMedBot, a no-code platform for digitising COVID-19 communication protocols that automated over 11 million forms. The founders learned from their customers how many people are excluded from modern technology and are stuck with complicated and inflexible tools offered by expensive software vendors.
Headquartered in Luxembourg, the company is fully remote and international, hiring for software development roles across Europe, the UK and the US. The seed round funding will be used to grow the product development team and roll-out Skippet to the company’s 200 MyMedBot customers and beyond. Skippet will be released in private beta in February 2022.
